alpelisib 50 MG Oral Granules [Vijoice]
- RxCUI
- 2680138
- RxNorm name
- alpelisib 50 MG Oral Granules [Vijoice]
- Display name
- alpelisib 50 MG Oral Granules [Vijoice]
- Full name
- alpelisib 50 MG Oral Granules [Vijoice]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIJOICE | ALPELISIB | Novartis Pharmaceuticals Corporation | 638069a4-aee0-46c9-9e21-54ad449c163c | 2025-11-04 | Warnings, Adverse reactions | 2680138 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 638069a4-aee0-46c9-9e21-54ad449c163c | alpelisib 50 MG Oral Granules [Vijoice] | SBD | 10 | These highlights do not include all the information needed to use VIJOICE safely and effectively. See full prescribing information for VIJOICE. VIJOICE ® (alpelisib) tablets, for oral use VIJOICE ® (alpelisib) oral granules Initial U.S. Approval: 2019 | 20251104 |
| 638069a4-aee0-46c9-9e21-54ad449c163c | Vijoice 50 MG Oral Granules | SY | 10 | These highlights do not include all the information needed to use VIJOICE safely and effectively. See full prescribing information for VIJOICE. VIJOICE ® (alpelisib) tablets, for oral use VIJOICE ® (alpelisib) oral granules Initial U.S. Approval: 2019 | 20251104 |
| 638069a4-aee0-46c9-9e21-54ad449c163c | Vijoice 50 MG Oral Granules | PSN | 10 | These highlights do not include all the information needed to use VIJOICE safely and effectively. See full prescribing information for VIJOICE. VIJOICE ® (alpelisib) tablets, for oral use VIJOICE ® (alpelisib) oral granules Initial U.S. Approval: 2019 | 20251104 |